A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, offering patients an alternative to chemotherapy and surgery.

An approach pioneered at Memorial Sloan Kettering Cancer Center (MSK) that caused rectal cancer tumors with a specific genetic mutation to disappear in 100% of clinical trial participants has been ...

CentraState Medical Center completed major upgrades to its cancer care units, ... CentraState unveils upgraded cancer care units (photos) Dawn Furnas // April 24, 2025 // ...

Experimental cancer drugs found to help some patients avoid surgery. Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery ...

Rectal cancer is a type of bowel cancer that develops in the last several centimeters of the large intestine, just before the anus. It’s one of the most common cancers in Europe, with over ...

Rectal cancer kills around 4,100 people in the UK (around 410 in Scotland) every year. Over the last 20 years, the incidence of early-onset rectal cancer has increased by 50.5% in the UK (53.6% in ...

A new study published in JAMA Network Open examines the relationship between the anatomical location of postcolonoscopy colorectal cancers (PCCRCs) and patient mortality outcomes within the ...